Erik Haeffler
Chief Executive Officer at Conveija Aktiebolag
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Marc Funk | M | 64 | 3 years | |
| Steven Klosk | M | 67 | 3 years | |
| Mark Burgess Keatley | M | 67 | 3 years | |
| Richard Ridinger | M | 66 | 3 years | |
| Erika Karin Elisabeth Henriksson | F | 43 | 3 years | |
| Henrik Giver | M | 35 | 3 years | |
| Jean-François Hilaire | M | 60 | 9 years | |
| Ulrike Lemke | F | - | 3 years | |
| Bernard Pluta | M | - | 9 years | |
| Kieran Chouhan | M | - | 5 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Anders O. Lönner | M | 79 | 14 years | |
| Björn Westberg | M | 62 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 13 years |
| Nils Bert Åke Eriksson | M | 80 | 16 years | |
| Lars Erik Westerberg | M | 76 | - | |
| Luca Rovati | M | 62 | - | |
| Anders Waldenstrom | M | 81 | 12 years | |
| Åsa Christina Knutsson | F | 62 |
University of Stockholm
| 3 years |
| Jonas Christer Angur von Hedenberg | M | 61 |
University of Stockholm
| 4 years |
| Anders Olof Adolf Ekblom | M | 70 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 7 years |
| Carola Elisabet Lemne | M | 66 | 2 years | |
| Joan Teresa Traynor | F | 65 | 2 years | |
| Guido Oelkers | M | 59 | - | |
| Anders Åberg | M | 66 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.
University of Stockholm
| 12 years |
| Eva Ulrika Sjökvist Saers | M | 62 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 4 years |
| Karen Lykke Sörensen | F | 62 | 4 years | |
| Carlos von Bonhorst | M | 67 | - | |
| Peter von Ehrenheim | M | 69 | - | |
| Lianjun Li | M | 61 |
University of Stockholm
| 3 years |
| Wenche Nelly A. Rolfsen Sandsborg | M | 72 | 3 years | |
| Christofer Edling | M | - |
University of Stockholm
| 9 years |
| Paula Treutiger | F | 57 | - | |
| Marie Helena Levander | F | 67 | - | |
| Carl Martin Svalstedt | M | 61 | 2 years | |
| Nils-Göran Pettersson | M | 79 | 16 years | |
| Ulf Ljungberg | M | - |
Astra AB
 Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden.
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 6 years |
| Per Johan Gösta Ryding | M | - |
University of Stockholm
| - |
| Christina Källenfors | F | 58 |
University of Stockholm
| 2 years |
| Per Eriksson | M | - |
University of Stockholm
| 1 years |
| Indrek Neivelt | M | 56 |
University of Stockholm
| 1 years |
| Staffan Fredholm | M | - |
University of Stockholm
| 4 years |
| Maria Bech | F | 56 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 5 years |
| Johan Patrik Philip Essehorn | M | 57 |
University of Stockholm
| 3 years |
| Niklas Norén | M | 52 |
University of Stockholm
| 6 years |
| Robert Mirsad Belkic | M | 54 |
University of Stockholm
| 4 years |
| Tobias Hägglöv | M | 46 | 3 years | |
| Jens Birgersson | M | 57 |
University of Stockholm
| 4 years |
| Katarina Ageborg | F | - |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 3 years |
| Ann Hook | F | - |
University of Stockholm
| 4 years |
| Jens Patrik Hedelin | M | 55 |
University of Stockholm
| 3 years |
| Richard Spivey | M | 74 | 8 years | |
| Ylva Julia Margareta Johansson | F | 60 |
University of Stockholm
| 1 years |
| Anna Sigurd | F | - |
University of Stockholm
| 3 years |
| Anna Jennehov | F | 60 |
University of Stockholm
| 4 years |
| Thomas Beck | M | - | 6 years | |
| Hans Jorgen Andersson | M | 59 |
University of Stockholm
| 4 years |
| Ulf Carl Fredrik Billing | M | 63 |
University of Stockholm
| 4 years |
| Ola Rollén | M | 59 |
University of Stockholm
| 4 years |
| Krister Widström | M | 62 |
University of Stockholm
| 4 years |
| Märta Maria Håkansson | F | 54 |
University of Stockholm
| 3 years |
| Niklas Lindecrantz | M | 56 |
University of Stockholm
| 1 years |
| Johan Selander | M | - |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 5 years |
| Mona Carolina Sachs | F | - |
University of Stockholm
| 17 years |
| Luis Luna | M | - |
University of Stockholm
| 3 years |
| Carlos von Bonhorst | M | - | 6 years | |
| Malin Barringer | F | - |
University of Stockholm
| 6 years |
| John Frederik Reinfeldt | M | 58 |
University of Stockholm
| 4 years |
| Aavo Kokk | M | 60 |
University of Stockholm
| 4 years |
| Marta E. Alarcon-Riquelme | M | - |
University of Stockholm
| 3 years |
| Jan Åkesson | M | 60 |
University of Stockholm
| 4 years |
| Lottie Knutson | F | 60 |
University of Stockholm
| 4 years |
| Erna Möller | F | - |
Astra AB
Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | - |
| Gustav Ragnar Bard | M | 60 |
University of Stockholm
| 4 years |
| Ulf Åke Lewander | M | 58 |
University of Stockholm
| 3 years |
| Stephan P. Hoffman | M | - |
University of Stockholm
| 3 years |
| Stefan Hansson | M | 58 |
University of Stockholm
| 4 years |
| Alf Gunnar Martin Nicklasson | M | 69 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 29 years |
| Thomas Lars Brodin | M | 60 |
University of Stockholm
| 4 years |
| Theodore Bergqvist | M | 54 |
University of Stockholm
| 3 years |
| Magnus Andersson | M | - |
University of Stockholm
| 4 years |
| Klas Peter Larsson | M | 60 |
University of Stockholm
| 3 years |
| Elena Lovén | F | 59 |
University of Stockholm
| 3 years |
| Gordana Landén | F | 59 |
University of Stockholm
| 4 years |
| Robert A. Conerly | M | 65 |
Astra AB
Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | 1 years |
| Johan Lannebo | M | 60 | - | |
| Asbjorn Höyheim | M | - |
University of Stockholm
| 4 years |
| Magdalena Wahlqvist Alveskog | F | 56 |
University of Stockholm
| 4 years |
| Ashwini Manmohan Vir Kakkar | M | 70 | - | |
| Gunilla Anders Ekström | M | 66 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | - |
| Mustafa Demirbüker | M | - |
University of Stockholm
| 3 years |
| Per Andersson | M | 57 |
University of Stockholm
| 3 years |
| Håkan Lars Mogren | M | 79 |
Astra AB
Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | 11 years |
| Mats E. Jonsson | M | - |
University of Stockholm
| 3 years |
| Petra Hedengran | F | 60 |
University of Stockholm
| 1 years |
| Andreas Forssell | M | 53 |
University of Stockholm
| 4 years |
| Richard Smith | M | 56 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | - |
| Per Brilioth | M | 55 |
University of Stockholm
| 3 years |
| Peter Wiklöf | M | 58 |
University of Stockholm
| 3 years |
| Niklas Lundquist | M | 54 |
University of Stockholm
| 5 years |
| Joachim Hansi Gahm | M | 60 |
University of Stockholm
| 2 years |
| Margit Mahlapuu | M | 52 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Erik Haeffler
- Personal Network
